Luteal Phase Support with 17·-Hydroxyprogesterone versus Unsupported

This study was designed to determine the efficacy of 17¬∑-hydroxyprogesterone caproate (17-OHPc) for luteal phase support in in vitro fertilization (IVF). For this purpose, a total of 86 IVF patients undergoing embryo transfer were randomly allocated to two groups as follows: (1) group A, including 43 patients who received the support of luteal …